Entrada Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Entrada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Entrada Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Entrada Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.6M | 98k | 15.98 |
| 2024-06-30 | $1.9M | 131k | 14.25 |
| 2024-03-31 | $987k | 70k | 14.17 |
| 2022-06-30 | $158k | 13k | 12.20 |
| 2022-03-31 | $605k | 64k | 9.39 |
| 2021-12-31 | $1.9M | 109k | 17.12 |